DMRA — Damora Therapeutics Share News
0.000.00%
Last trade - 00:00Galecto rises on plans to explore strategic alternatives, job cuts
U.S. STOCKS ON THE MOVE-Arcellx, U.S. Steel, Copper miners
U.S. STOCKS ON THE MOVE-Getty Images, Tiziana, LL Flooring
U.S. STOCKS ON THE MOVE-SCYNEXIS, Paysafe, Big banks
Galecto slumps after scrapping development of lung disease treatment
Galecto to discontinue development of lung disease treatment (updated)
Galecto to discontinue development of lung disease treatment
Brief: Galecto Announces Topline Results From Phase 2B Galactic-1 Trial Of Gb0139 For The Treatment Of Idiopathic Pulmonary Fibrosis
Galecto Inc reports results for the quarter ended in June - Earnings Summary
Brief: Galecto Set To Join Russell Microcap Index
U.S. RESEARCH ROUNDUP- Galecto, Palo Alto Networks, Zscaler
U.S. STOCKS ON THE MOVE-Galecto, Pinterest, Standard Lithium
Galecto rises on completing dosing for lung disease drug trial
Brief: Galecto Completes Dosing In 52-Week Phase 2b GALACTIC-1 Trial Of GB0139 In Idiopathic Pulmonary Fibrosis
Brief: Galecto Reports First Quarter Operating And Financial Results
Brief: Galecto posts Q1 basic EPS USD -0.51
Galecto Inc expected to post a loss of 62 cents a share - Earnings Preview
Galecto Inc reports results for the quarter ended in December - Earnings Summary
Brief: Galecto Reports Operating & Financial Results Year Ended Dec 31, 2022